Dr. Ana Oton
Research ScientistEli Lilly and Company, USA
Highest Degree
PostDoc Fellow in Hematology from University of Pittsburgh School of Medicine, USA
Share this Profile
Area of Interest:
Selected Publications
- Hess, L.M., Z.L. Cui, X.I. Li, A.B. Oton, S. Shortenhaus and I.A. Watson, 2018. Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States. J. Med. Econ., (In Press). 10.1080/13696998.2018.1467918.
CrossRef | Direct Link | - Langer, C.J., L.G. Paz-Ares, A.J. Wozniak, C. Gridelli and F. de Marinis et al., 2017. Safety analyses of pemetrexed-cisplatin and pemetrexed maintenance therapies in patients with advanced non-squamous NSCLC: Retrospective analyses from 2 phase III studies. Clin. Lung Cancer, 18: 489-496.
CrossRef | Direct Link | - Hess, L.M., Z.L. Cui, Y. Wu, Y. Fang, P.J. Gaynor and A.B. Oton, 2017. Current and projected patient and insurer costs for the care of patients with non-small cell lung cancer in the United States through 2040. J. Med. Econ., 20: 850-862.
CrossRef | Direct Link | - Hess, L.M., D.M. Kern, G.C. Carter, K. Winfree, L. Wang, A. Sontag and A.B. Oton, 2017. Real-world treatment sequences and outcomes among patients with non-small cell lung cancer (RESOUNDS) in the United States: Study protocol. JMIR Res. Protocols, Vol. 6, No. 10. 10.2196/resprot.7750.
CrossRef | Direct Link | - Hess, L.M., A. Louder, K. Winfree, Y.E. Zhu, A.B. Oton and R. Nair, 2017. Factors associated with adherence to and treatment duration of erlotinib among patients with non-small cell lung cancer. J. Managed Care Specialty Pharm., 23: 643-652.
CrossRef | Direct Link | - Rolfo, C., C. Caglevic, D. Bretel, D. Hong and L.E. Raez et al., 2016. Cancer clinical research in Latin America: Current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015. ESMO Open, Vol. 1, No. 4. 10.1136/esmoopen-2016-000055.
CrossRef | Direct Link | - Lopez-Chavez, A., A. Thomas, M.O. Evbuomwan, L. Xi and G. Chun et al., 2016. EGFR mutations in Latinos from the United States and Latin America. J. Global Oncol., 2: 259-267.
CrossRef | Direct Link | - Weickhardt, A.J., R.C. Doebele, W.T. Purcell, P.A. Bunn and A.B. Oton et al., 2013. Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients. Cancer, 119: 2383-2390.
CrossRef | Direct Link | - Weickhardt, A.J., M.S. Rothman, S. Salian-Mehta, K. Kiseljak-Vassiliades and A.B. Oton et al., 2012. Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer. Cancer, 118: 5302-5309.
CrossRef | Direct Link | - Doebele, R.C., X. Lu, C. Sumey, D.A. Maxson and A.J. Weickhardt et al., 2012. Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer. Cancer, 118: 4502-4511.
CrossRef | Direct Link | - Camidge, D.R., S.A. Kono, X. Lu, S. Okuyama and A.E. Baron et al., 2011. Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed. J. Thoracic Oncol., 6: 774-780.
CrossRef | Direct Link | - Doebele, R.C., A.B. Oton, N. Peled, D.R. Camidge and P.A. Bunn Jr., 2010. New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer. Lung Cancer, 69: 1-12.
CrossRef | Direct Link | - Calverley, D.C., T.L. Phang, Q.G. Choudhury, B. Gao, A.B. Oton, M.J. Weyant and M.W. Geraci, 2010. Significant downregulation of platelet gene expression in metastatic lung cancer. Clin. Transl. Sci., 3: 227-232.
CrossRef | Direct Link | - Peled, N., A.B. Oton, F.R. Hirsch and P. Bunn, 2009. MAGE A3 antigen-specific cancer immunotherapeutic. Immunotherapy, 1: 19-25.
CrossRef | Direct Link | - Oton, A.B., H. Wang, X. Leleu, M.F. Melhem and D. George et al., 2008. Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant. Leukemia Lymphoma, 49: 1738-1744.
CrossRef | Direct Link | - Alsayed, Y., X. Leleu, A. Leontovich, A.B. Oton, M. Melhem, D. George and I.M. Ghobrial, 2008. Proteomics analysis in post-transplant lymphoproliferative disorders. Eur. J. Haematol., 81: 298-303.
CrossRef | Direct Link | - Owonikoko, T.K., C.C. Ragin, C.P. Belani, A.B. Oton, W.E. Gooding, E. Taioli and S.S. Ramalingam, 2007. Lung cancer in elderly patients: An analysis of the surveillance, epidemiology and end results database. J. Clin. Oncol., 25: 5570-5577.
CrossRef | PubMed | Direct Link |